Investor Type | Firm |
Industries | BioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Early,Seed,Later, Series A, Series B |
Investing | United States |
Investment Range | $5,000,000 - $25,000,000 |
Investment Sweet Spot | $10,000,000 |
Assets Under Management | $145,000,000 |
Founded in 1998, BioVentures Investors is a venture capital investment firm based in Wellesley, Massachusetts with a focus on the MedTech sector, including medical devices, diagnostics, and related commercial technology sectors. The firm is committed to the innovators changing the practice of medicine and frequently invests in companies developing leading-edge medical technologies. BioVentures Investors aims to improve healthcare outcomes globally by creating dynamic solutions. With assets under management totaling $145 million, their investment scope ranges from $5 million to $25 million, having a sweet spot of around $10 million per investment. They specialize in various funding stages such as seed, early, later, Series A, and Series B investments. The firm prides itself on its experienced investment team that leverages industry experience, scientific and clinical backgrounds, regulatory and policy knowledge, operating know-how, and financial acumen. This expertise is employed to select promising investment opportunities develop companies strategically, and successfully execute exit strategies. BioVentures Investors positions itself as a trusted partner, providing not only capital but also guidance and advice to enhance the value of its portfolio companies significantly. They actively engage with their companies, helping them navigate the healthcare landscape and have a policy of aligning their investment strategy with the dynamics of the MedTech industry. The firm's track record reflects an emphasis on technological advancements that benefit patients, healthcare providers, and payers, contribute to combating rising healthcare costs, and are attractive acquisition targets for larger entities. BioVentures Investors remains a proactive entity in pushing the envelope of innovation and accelerating the pace of progress within the MedTech field, ensuring their portfolio companies are at the forefront of medical advancements.